WHO ICTRP trial
Randomised trial of neo-adjuvant therapy in patients with stage IIIA non small…
ISRCTN54157750 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN54157750 |
|---|---|
| Public title | Randomised trial of neo-adjuvant therapy in patients with stage IIIA non small cell lung cancer |
| Primary sponsor | Medical Research Council (MRC) (UK) |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase III |
| Countries | United Kingdom |
| Conditions | Cancer Cancer Non small cell lung (NSCL) cancer |
| Interventions | 1. One group receives standard therapy with thoracic radiotherapy 2. The other group receives chemotherapy followed, if feasible, by surgery |
| Registration date | Feb 28, 2001 |
| Target size | 350 |
| Secondary IDs | LU20 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: